Riskpilot← Back to searchSign inGet full accessOsstell AB
ABActiveOrg 5566124938Stampgatan 14Research and experimental development on natural sciences and engineering · NACE 7210Est. 200117 employees
Revenue 2025
SEK 44,4M
-21% vs 2024
EBITDA margin
-18.7%
-1336% vs 2024
Equity ratio
43.4%
Financial strength
Net profit 2025
SEK -7,1M
-1862% vs 2024
| Revenue | SEK 44,4M | -21% |
| EBITDA | SEK -8,3M | -1336% |
| Net profit | SEK -7,1M | -1862% |
| Total assets | SEK 27,2M | -15% |
| Equity | SEK 11,8M | -37% |
| Employees | 17 | — |
Legal name
Osstell AB
Org number
5566124938
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
21 juni 2001
Share capital
SEK 100 000
Employees
17 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Maier, Klaus Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning, utveckling, produktion, marknadsföring, försäljning och utbildning inom medicinsk mätteknik samt därmed förenlig verksamhet.
Address
Stampgatan 14
Phone
+46313408250
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 34 176 | 31 103 | 51 192 | 43 551 | 46 200 | 55 185 | 56 290 | 44 367 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 3 215 | −5 728 | −3 184 | 1 323 | 5 682 | −1 656 | −1 916 | 2 440 | 672 | −8 306 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — |
| EBIT | 3 215 | −5 728 | −3 184 | 1 323 | 5 682 | −1 656 | −1 916 | 2 440 | 672 | −8 306 |
| Net financials | 1 628 | −1 293 | 1 334 | 1 665 | −1 944 | −12 992 | 775 | −882 | −1 711 | −555 |
| Profit before tax | 2 192 | −4 370 | −1 850 | 2 988 | 138 | −10 780 | −1 141 | 1 799 | −412 | −8 734 |
| Tax | −305 | 923 | 378 | −694 | −56 | −469 | 137 | −432 | 51 | 1 650 |
| Net profit | 1 887 | −3 447 | −1 472 | 2 294 | 82 | −11 249 | −1 004 | 1 367 | −361 | −7 084 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 51 289 | 51 557 | 55 479 | 56 823 | 57 118 | 39 169 | 37 679 | 41 579 | 32 051 | 27 209 |
| Equity | 23 235 | 19 788 | 27 771 | 30 064 | 30 146 | 18 897 | 17 894 | 19 260 | 18 899 | 11 814 |
| Long-term debt | 2 000 | 4 000 | 10 144 | 10 762 | 10 197 | 9 890 | 10 521 | 11 713 | 5 962 | 6 039 |
| Short-term debt | 23 170 | 27 553 | 17 350 | 15 717 | 12 908 | 9 478 | 8 394 | 9 704 | 6 328 | 8 474 |
| Total debt | 25 170 | 31 553 | 27 494 | 26 479 | 23 105 | 19 368 | 18 915 | 21 417 | 12 290 | 14 513 |
EBITDA margin
-18.7%
This company
15.8%
Market median
-218% vs market
20162025
Equity ratio
43.4%
This company
38.2%
Market median
+14% vs market
20162025
Return on equity
-60.0%
This company
18.4%
Market median
-426% vs market
20162025
Net profit margin
-16.0%
This company
8.1%
Market median
-298% vs market
20162025
Asset turnover
1.63×
This company
1.12×
Market median
+46% vs market
20162025
Debt / equity
1.30×
This company
0.62×
Market median
-110% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PO Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AL Chief Auditor | Chief Auditor | 2022 | — | — |
KJ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
W&H DENTALWERK BÜRMOOS GMBH | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
W&H DENTALWERK BÜRMOOS GMBH
Osstell AB (this company)Board members of Osstell AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Olof Gunnar Lundgren | Chief Executive Officer | 0 companies |
| Anton Lars van Dijck | Chief Auditor | 0 companies |
| Kurt Jonas Ehinger | Chief Executive Officer | 0 companies |
| Karin Malin Tureson Gustavsson | Chief Executive Officer | 0 companies |
| Nicole Gitel Winitsky | Board of Directors | 0 companies |
| Johan Olof Palmgren | Deputy Board Member | 0 companies |
| Carsten Nils Erik Browall | Board of Directors | 0 companies |
| Martin Schwenoha | Board of Directors | 0 companies |
| Klaus Maier | Chairman | 0 companies |
| Angelo Bonzi | Board of Directors | 0 companies |
| Michael Reiter | Board of Directors | 0 companies |